Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

Here's a real investment backer - Dominion go away

http://ih.advfn.com/p.php?pid=nmona&article=61169657

Move Over Celgene Here Comes Nuvilex and $27 Million to Advance Its Pancreatic Cancer Clinical Trials

NEW YORK, NY--(Marketwired - Feb 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) just became relevant in the biotech industry. The company can now move forward with its clinical trials for the treatment of advanced inoperable pancreatic cancer after Nuvilex landed a $27 million funding deal that could change the sector for years to come. Funding is always the biggest hurdle for any small biotechnology or pharmaceutical firm, and its why larger firms with competing treatments can often sit back without worry of new competition.

But, as many biotech investors know, it only takes one believer with deep pockets to come along and fund a firm's clinical trials. It is then that big pharma becomes a bit more aware of their new competitor's future. Nuvilex has found that believer, and it's in the form of an institutional investor that will dedicate at least $27 million towards Nuvilex's future and its Cell-in-a-Box based pancreatic cancer treatment.


********************************************************************************************************************************************************

Send your dilutive financing complaints here:

[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]